Messe Muenchen India organized a regional edition of analytica Anacon India and India Lab Expo, the market leading trade fairs for laboratory technology, analysis, biotechnology and diagnostics. This is the maiden edition which is currently being held in Mumbai from April 25-26, 2018 at the Bombay Exhibition Centre, Goregaon. The expo attracted over 4000 visitors and showcased over 100 national and international exhibitors from Germany, USA, China, Japan and Korea.
The exhibition had a grandeur opening with the presence of eminent industry players like Mr. Satya Chandra Sekhar, Vice President and Head, Reliance Life Sciences, Dr. Reba Chhabra, Deputy Director Quality Control and Head, National Institute of Biologicals, Ministry of Health and Family Welfare, Government of India, Mr. Sampath Srisailam, Senior Group Leader, Syngene International Limited, Dr. Dibyendu Saha, Senior Science, Standards Liaison – Global Biologics, United States Pharmacopeia and Mr. Vijay Nag Thota, Deputy General Manager – Biologics Regulatory & Product Strategies, Hetero Drugs and Mr. Bhupinder Singh, CEO, Messe Muenchen India.
The Analytical instrument industry is majorly import driven with 83% share in 2016, expected to come down to 74% by 2020 having CAGR 22% between 2012-2020 with major importing nations like China, USA and Europe, as per a recent report by Euro Asia Consulting.
Indian Analytical instrument consumption is seen in key application sectors such as Pharmaceutical, Biotechnology, Testing, Inspection & Certification industry and Government & Academia. Growth of analytical instruments market largely depends on the performance and R & D spending of industries such as Pharmaceutical, Biotechnology, Chemical and Oil & Gas etc. Life sciences, Food & Beverage are also emerging as prominent sectors which are expected to fuel the market for analytical instruments in the coming years.
Mr. Bhupinder Singh, CEO of Messe Muenchen India said, “Analytical Instruments industry can be made into a robust eco-system by creating competitive positioning through driving sectors’ growth, R & D, local manufacturing focus and government policies. Demand for customized instrumentation from end-user segments such as the pharmaceutical and biotechnology sectors is primarily driving the analytical instruments market in India.”
India remains heavily import dependent (70-80%) to meet Analytical instruments demand, wherein high end equipment are imported, while local manufacturing is limited to basic to medium technology equipment. Analytical instrument industry is evolving with trends such as smart technology adoption, miniaturization, portable instruments and customization; customization being highly demanding by end users. Indian analytical instruments industry is emerging (2 Billion EUR) and has potential opportunities mainly driven by shifting customer focus, foreign player’s footprint and emerging application sectors.
India’s pharmaceutical sector has reformed into a global R&D hub. India’s pharma industry exhibits strong manufacturing and export competencies allowing it to be one of the most competitive regions globally. The growth in Life Sciences, Pharmaceutical Research, Biotechnology, Chemical, Oil & Gas, Food & Beverage industry is fueling the consumption of analytical instrument in India. Indian analytical instrument industry is expected to reach 2.4 billion EUR by 2020 having CAGR of 17% which currently stands at 4% of global market.